Literature DB >> 15822050

Role of oxidative stress in diabetic nephropathy.

Nina Vasavada1, Rajiv Agarwal.   

Abstract

Accumulating research suggests that oxidative stress is a significant contributor to the pathogenesis of diabetic nephropathy. The normal kidney generates a substantial amount of oxidative stress because of its high metabolic activity that is balanced by an extensive antioxidant system. However, in pathologic states such as hyperglycemia, nitroso-oxidant balance shifts toward a pro-oxidant state that accelerates tissue and vascular injury. This oxidative damage progresses concomitant with worsening glucose metabolism, vascular dysfunction, and kidney disease. Accordingly, strategies to reduce oxidative stress in diabetes mellitus may exert favorable effects on the progression of diabetic nephropathy.

Entities:  

Mesh:

Year:  2005        PMID: 15822050     DOI: 10.1053/j.ackd.2005.01.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  23 in total

1.  The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.

Authors:  Abdolrahim Nikzamir; Alireza Esteghamati; Amir Abbas Hammedian; Touraj Mahmoudi
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

Review 2.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

3.  Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy.

Authors:  Desirée Luis-Rodríguez; Alberto Martínez-Castelao; José Luis Górriz; Fernando De-Álvaro; Juan F Navarro-González
Journal:  World J Diabetes       Date:  2012-01-15

4.  Mentha longifolia Alleviates Exogenous Serotonin-Induced Diabetic Hypoglycemia and Relieves Renal Toxicity via ROS Regulation.

Authors:  Tahir Ali; Ayesha Ishtiaq; Iram Mushtaq; Neelum Ayaz; Muhammad Ishtiaq Jan; Wajiha Khan; Uzma Khan; Iram Murtaza
Journal:  Plant Foods Hum Nutr       Date:  2021-10-30       Impact factor: 3.921

5.  Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Authors:  Hongyu Zhang; Jharna Saha; Jaeman Byun; MaryLee Schin; Matthew Lorenz; Robert T Kennedy; Matthias Kretzler; Eva L Feldman; Subramaniam Pennathur; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

Review 6.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

Authors:  Yves Gorin; Karen Block
Journal:  Free Radic Biol Med       Date:  2013-03-23       Impact factor: 7.376

7.  Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.

Authors:  Riyaz Mohamed; Calpurnia Jayakumar; Feng Chen; David Fulton; David Stepp; Ron T Gansevoort; Ganesan Ramesh
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

Review 8.  Diabetic nephropathy and antioxidants.

Authors:  Majid Tavafi
Journal:  J Nephropathol       Date:  2013-01-01

9.  Diabetic Kidney Disease.

Authors:  Victoria E Bouhairie; Janet B McGill
Journal:  Mo Med       Date:  2016 Sep-Oct

10.  The effect of pioglitazone on antioxidant levels and renal histopathology in streptozotocin-induced diabetic rats.

Authors:  Munire Kuru Karabas; Mediha Ayhan; Engin Guney; Mukadder Serter; Ibrahim Meteoglu
Journal:  ISRN Endocrinol       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.